Lower injection‐site reactions and long‐term safety, immunogenicity, and efficacy of etanercept biosimilar YLB113: Results from a post‐hoc analysis of a double‐blind, randomized, phase III comparative study and its open‐label extension in patients with rheumatoid arthritis

Autor: Yamanaka, Hisashi1,2,3 (AUTHOR), Tanaka, Yoshiya4 (AUTHOR), Hibino, Toshihiko5 (AUTHOR), Unmesh, Gopalakrishnan6 (AUTHOR), Shah, Chirag7 (AUTHOR), Bakhle, Dhananjay7 (AUTHOR), Stefanidis, Dimitris8 (AUTHOR) dimitris.stefanidis@viatris.com
Zdroj: International Journal of Rheumatic Diseases. Jan2023, Vol. 26 Issue 1, p108-115. 8p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje